Literature DB >> 11854909

Expression of liver cancer associated gene HCCA3.

Z X Wang1, G F Hu, H Y Wang, M C Wu.   

Abstract

AIM: To study and clone a novel liver cancer related gene, and to explore the molecular basis of liver cancer genesis.
METHODS: Using mRNA differential display polymerase chain reaction (DDPCR), we investigated the difference of mRNA in human hepatocellular carcinoma (HCC) and paired surrounding liver tissues, and got a gene probe. By screening a human placenta cDNA library and genomic homologous extend, we obtained a full-length cDNA named HCCA3. We analyzed the expression of this novel gene in 42 pairs of HCC and the surrounding liver tissues, and distribution in human normal tissues by means of Northern blot assay.
RESULTS: A full-length cDNA of liver cancer associated gene HCCA3 has been submitted to the GeneBank nucleotide sequence databases (Accession No. AF276707). The positive expression rate of this gene was 78.6% (33/42) in HCC tissues, and the clinical pathological data showed that the HCCA3 was closely associated with the invasion of tumor capsule (P=0.023) and adjacant small metastasis satellite nodules lesions (P=0.041). The HCCA3 was widely distributed in the human normal tissues, which was intensively expressed in lungs, brain and colon tissues, while lowly expressed in the liver tissues.
CONCLUSION: A novel full-length cDNA was cloned and differentiated, which was highly expressed in liver cancer tissues. The high expression was closely related to the tumor invasiveness and metastasis,that may be the late heredited change in HCC genesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11854909      PMCID: PMC4695602          DOI: 10.3748/wjg.v7.i6.821

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  52 in total

1.  Potential roles of tumor suppressor genes and microsatellite instability in hepatocellular carcinogenesis in southern African blacks.

Authors:  Lewis R Roberts; Nicholas F LaRusso
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

2.  Overexpression of P-glycoprotein in hepatocellular carcinoma and its clinical implication.

Authors:  Xian-Bing Kong; Zu-Kui Yang; Li-Jian Liang; Jie-Fu Huang; Han-Liang Lin
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

3.  Inhibitory effect of IGF- II antisense RNA on malignant phenotype of hepatocellular carcinoma.

Authors:  Dong-Hua Yang; Ming-Qing Zhang; Jiang Du; Chong Xu; Qiao-Ming Liang; Ji-Fang Mao; Han-Rong Qin; Zi-Rong Fan
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

4.  Expression of regulating apoptosis gene and apoptosis index in primary liver cancer.

Authors:  Hong-Yu Xu; You-Lin Yang; Xi-Li Guan; Guang Song; Ai-Min Jiang; Li-Jun Shi
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

5.  Characterization of six tumor suppressor genes and microsatellite instability in hepatocellular carcinoma in southern African blacks.

Authors:  C Martins; M A Kedda; M C Kew
Journal:  World J Gastroenterol       Date:  1999-12       Impact factor: 5.742

6.  Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein.

Authors:  J Fan; Z Q Wu; Z Y Tang; J Zhou; S J Qiu; Z C Ma; X D Zhou; S L Ye
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

7.  A novel member of the NF2/ERM/4.1 superfamily with growth suppressing properties in lung cancer.

Authors:  Y K Tran; O Bögler; K M Gorse; I Wieland; M R Green; I F Newsham
Journal:  Cancer Res       Date:  1999-01-01       Impact factor: 12.701

8.  Identification and characterization of genes associated with human hepatocellular carcinogenesis.

Authors:  N Kondoh; T Wakatsuki; A Ryo; A Hada; T Aihara; S Horiuchi; N Goseki; O Matsubara; K Takenaka; M Shichita; K Tanaka; M Shuda; M Yamamoto
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

9.  Identification of DMC1, a novel gene in the TOC region on 17q25.1 that shows loss of expression in multiple human cancers.

Authors:  H Harada; H Nagai; M Tsuneizumi; I Mikami; S Sugano; M Emi
Journal:  J Hum Genet       Date:  2001       Impact factor: 3.172

10.  Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization.

Authors:  Y Miyasaka; N Enomoto; K Nagayama; N Izumi; F Marumo; M Watanabe; C Sato
Journal:  Br J Cancer       Date:  2001-07-20       Impact factor: 7.640

View more
  5 in total

1.  Applying a highly specific and reproducible cDNA RDA method to clone garlic up-regulated genes in human gastric cancer cells.

Authors:  Yong Li; You-Yong Lu
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

2.  Effect of arsenic trioxide on rat hepatocellular carcinoma and its renal cytotoxity.

Authors:  Shao-Shan Wang; Ti Zhang; Xi-Lu Wang; Li Hong; Qing-Hui Qi
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

3.  The analysis of gamma-glutamyl transpeptidase gene in different type liver tissues.

Authors:  Guo-Qing Han; Cheng-Yong Qin; Rong-Hua Shu
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

4.  Differential expression of genes during aflatoxin B(1)-induced hepatocarcinogenesis in tree shrews.

Authors:  Yuan Li; Da-Fang Wan; Jian-Jia Su; Ji Cao; Chao Ou; Xiao-Kun Qiu; Ke-Chen Ban; Chun Yang; Liu-Liang Qin; Dan Luo; Hui-Fen Yue; Li-Sheng Zhang; Jian-Ren Gu
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

5.  ADD66, a gene involved in the endoplasmic reticulum-associated degradation of alpha-1-antitrypsin-Z in yeast, facilitates proteasome activity and assembly.

Authors:  Craig M Scott; Kristina B Kruse; Béla Z Schmidt; David H Perlmutter; Ardythe A McCracken; Jeffrey L Brodsky
Journal:  Mol Biol Cell       Date:  2007-07-18       Impact factor: 4.138

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.